EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here?

Jenny Z Yang iD, David S Poch iD, Lawrence Ang, Ehtisham Mahmud, Nick H Kim

Pulmonary Circulation · 2023-10 · 13 (4)

DOI: 10.1002/pul2.12312 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pulmonary Circulation, online erschienen am 20.11.2023. Verfasst von Jenny Z Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine UC San Diego La Jolla California USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by persistent organized thromboembolic obstruction of the pulmonary arteries from incompletely resolved pulmonary embolism. The treatment of choice is pulmonary thromboendarterectomy (PTE) surgery and all patients should be evaluated for operability candidacy. Despite advancements in PTE technique allowing more segmental–subsegmental surgeries, up to a third of patients with CTEPH may still be considered inoperable. Over the past decade, there have been increasing treatment options for these inoperable CTEPH patients. Balloon pulmonary angioplasty (BPA) is a percutaneous‐based interventional treatment option for select CTEPH cases. Early BPA experiences were plagued by high complication rates, but further refinements in technique and equipment pioneered by Japan led to the worldwide spread and adoption of BPA. Multiple centers have shown that patients experience significant improvements in hemodynamics, quality of life, exercise capacity, and survival with BPA treatment. There remain many questions on best practices, but BPA has evolved into a pivotal cornerstone of CTEPH treatment.

Schlagwörter

Stichwörter der Autor:innen

BPACTEPHballoon pulmonary angioplastychronic thromboembolic pulmonary diseasepulmonary vascular

Autor:innen und Institutionen

  • Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine UC San Diego La Jolla California USA.
  • Department of Medicine, Division of Cardiovascular Medicine UC San Diego La Jolla California USA.

ORCID-Profile: Jenny Z Yang, David S Poch

Zitieren

APA

Yang, J. Z., Poch, D. S., Ang, L., Mahmud, E., & Kim, N. H. (2023). Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here?. Pulmonary Circulation, 13(4). https://doi.org/10.1002/pul2.12312

Vancouver

Yang JZ, Poch DS, Ang L, Mahmud E, Kim NH. Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here?. Pulmonary Circulation. 2023;13(4). doi:10.1002/pul2.12312

BibTeX
@article{Yang2023,
  author = {Yang, Jenny Z and Poch, David S and Ang, Lawrence and Mahmud, Ehtisham and Kim, Nick H},
  title = {Balloon pulmonary angioplasty in the current era of CTEPH treatment: How did we get here?},
  journal = {Pulmonary Circulation},
  year = {2023},
  volume = {13},
  number = {4},
  doi = {10.1002/pul2.12312}
}
Kostenlos starten →